Phase 2-3 Clinical Trial Services
Clinilabs is the only global, full-service contract research organization (CRO) that focuses exclusively on central nervous system (CNS) drug, device, and technology development. Our clinical trial services offer a comprehensive range of high-quality, timely, and cost-effective phase 2-3 clinical development services to help our customers expedite new CNS medications, therapies, and devices to the market. Our expertise lies in the development of treatments for psychiatric, neurological, and substance abuse disorders, including mental health disorders, Alzheimer’s and Parkinson’s disease, migraine headaches, opioid use disorders, and rare diseases within the CNS category.
Clinilabs has global capabilities and conducts phase 2-3 clinical trials in Asia through Clinilabs Asia Pacific and in Europe. With over 20 years of experience,
Clinilabs has conducted more than 720 CNS clinical trials and has played a pivotal role in approving 22 new therapies across 13 CNS indications. We are a patient-centric partner who shares your goal of accelerating new CNS medicines to the market to improve patients’ lives.
If you think compliance is expensive, try non-compliance.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
I have no ideology. My ideology is health.
Good information is the best medicine.
One sometimes finds what one is not looking for.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
All truths are easy to understand once they are discovered; the point is to discover them.
There is so much more to be done; the patients are waiting.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
I am not accustomed to saying anything with certainty after only one or two observations.
The pace of discovery is going unbelievably fast.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
One never notices what has been done; one can only see what remains to be done.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
Drugs don’t work in patients who don’t take them.
The reward for work well done is the opportunity to do more.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
The best way to predict the future is to invent it.